Insider Buying: Emmaus Life Sciences (NASDAQ:EMMA) Director Buys 12,545 Shares of Stock

Share on StockTwits

Emmaus Life Sciences (NASDAQ:EMMA) Director Wei Peu Zen bought 12,545 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The shares were bought at an average price of $4.20 per share, for a total transaction of $52,689.00.

Wei Peu Zen also recently made the following trade(s):

  • On Monday, September 9th, Wei Peu Zen bought 40,000 shares of Emmaus Life Sciences stock. The shares were bought at an average price of $4.25 per share, for a total transaction of $170,000.00.
  • On Friday, August 30th, Wei Peu Zen acquired 3,400 shares of Emmaus Life Sciences stock. The stock was acquired at an average price of $3.30 per share, for a total transaction of $11,220.00.
  • On Wednesday, August 28th, Wei Peu Zen acquired 2,345 shares of Emmaus Life Sciences stock. The stock was acquired at an average price of $2.80 per share, for a total transaction of $6,566.00.

NASDAQ:EMMA opened at $2.77 on Thursday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.44 and a current ratio of 1.44. The company has a market capitalization of $131.48 million, a price-to-earnings ratio of -0.25 and a beta of 2.91. Emmaus Life Sciences has a 12-month low of $2.49 and a 12-month high of $14.70.

Separately, Zacks Investment Research upgraded Emmaus Life Sciences from a “hold” rating to a “buy” rating and set a $6.75 price objective on the stock in a research note on Tuesday, July 30th.

Emmaus Life Sciences Company Profile

Emmaus Life Sciences, Inc engages in the discovery, development, and commercialization of treatments and therapies primarily for rare and orphan diseases in the United States and internationally. It provides Endari, which is L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older; NutreStore L-glutamine powder; and AminoPure, a nutritional supplement.

Read More: What is the price-to-earnings growth (PEG) ratio?

Insider Buying and Selling by Quarter for Emmaus Life Sciences (NASDAQ:EMMA)

Receive News & Ratings for Emmaus Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emmaus Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Insider Selling: bluebird bio Inc  Insider Sells 850 Shares of Stock
Insider Selling: bluebird bio Inc Insider Sells 850 Shares of Stock
Elizabeth H. Weatherman Acquires 8,382 Shares of Vapotherm Inc  Stock
Elizabeth H. Weatherman Acquires 8,382 Shares of Vapotherm Inc Stock
L. Chance Allred Sells 8,085 Shares of Vivint Solar Inc  Stock
L. Chance Allred Sells 8,085 Shares of Vivint Solar Inc Stock
Mitchell Shuster Steiner Sells 30,000 Shares of Veru Inc  Stock
Mitchell Shuster Steiner Sells 30,000 Shares of Veru Inc Stock
SONOVA HLDG AG/ADR  Lifted to Buy at Jefferies Financial Group
SONOVA HLDG AG/ADR Lifted to Buy at Jefferies Financial Group
Sino United Worldwide Consolidated  Lowered to “Hold” at ValuEngine
Sino United Worldwide Consolidated Lowered to “Hold” at ValuEngine


© 2006-2019 Ticker Report